Zurcher Kantonalbank (Zurich Cantonalbank) Astrazeneca PLC Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Astrazeneca PLC stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 150 shares of AZN stock, worth $11,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$11,431
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.6 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.13 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.86 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.82 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...